KENDALL BAILEY: Open Payments
NPI 1194571216 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,861 in 132 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,382 · 2025 $2,861
Food & beverage: $2,851Education: $10
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $557 |
| ABBVIE INC. | 33 | $509 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $290 |
| Regeneron Healthcare Solutions, Inc. | 4 | $214 |
| Novartis Pharmaceuticals Corporation | 10 | $213 |
| Galderma Laboratories, L.P. | 7 | $191 |
| LEO Pharma Inc. | 12 | $148 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $96 |
| Janssen Biotech, Inc. | 4 | $88 |
| Arcutis Biotherapeutics, Inc. | 4 | $86 |
Products named: Bimzelx, SKYRIZI, DUPIXENT, COSENTYX, BOTOX, ADBRY, Odomzo, TREMFYA.
Industry payments across AZ — which companies pay providers there.
